SlideShare a Scribd company logo
1 of 93
BLOOD
Sreenu Thalla
Assistant Professor
Department of Pharmacology
4/3/2024 1
Primary Functions of the Circulatory System
1) Transportation
- Deliver life-supporting materials, i.e., O2, glucose,
amino acid, fatty acids, vitamins, minerals, etc.
- Deliver regulating signals, i.e., hormones to tissue
cells
- Collect waste products from tissue cells and
deliver to special organs (kidney, lung) for disposal
- Distribute heat throughout the body
4/3/2024 2
Sreenu Thalla, Department of
Pharmacology
Primary Functions of the Circulatory System
2) Protection
- Special components of the blood patrol the whole
body and fight against invaded microorganisms and
cancerous cells.
cell
cell
cell
cell
cell
cell
cell
H2O
Glucose
Lipids
Amino acids
Vitamins
Minerals
O2
pH 7.35-7.45
~38° C
290 mOsm
4/3/2024 3
Sreenu Thalla, Department of
Pharmacology
4/3/2024 4
Sreenu Thalla, Department of
Pharmacology
1) Plasma
2) The Formed Elements
(blood cells/cell fragments)
Composition of the Blood
4/3/2024 5
Sreenu Thalla, Department of
Pharmacology
General Properties of Whole Blood
- Fraction of body weight
- Volume
- temperature
- pH 7.35 - 7.45
- Viscosity (relative to water)
- Osmolarity
- Mean salinity (mainly NaCl)
8%
Female: 4-5 L
Male: 5-6 L
38 C (100.4 F)
Whole blood: 4.5-5.5
plasma: 2.0
280-300 mOsm/L
0.85%
4/3/2024 6
Sreenu Thalla, Department of
Pharmacology
Hematocrit
RBCs as percent of total blood
volume
- Female: 37%-48%
- male: 45%-52%
100%
4/3/2024 7
Sreenu Thalla, Department of
Pharmacology
Hemoglobin
Female: 12-16 g/100 ml
male: 13-18 g/100 ml
Mean RBC count
Female: 4.8 million/l
male: 5.4 million/l
Platelet counts 130,000-360,000/l
Total WBC counts 4,000-11,000/l
General Properties of Whole Blood (continued)
4/3/2024 8
Sreenu Thalla, Department of
Pharmacology
Plasma
4/3/2024 9
Sreenu Thalla, Department of
Pharmacology
Water 92% by weight
Proteins Total 6-9 g/100 ml
Albumin 60% of total plasma protein
Globulin 36% of total plasma protein
Fibrinogen 4% of total plasma protein
Enzymes of diagnostic value trace
Glucose (dextrose) 70-110 mg/100 ml
Amino acid 33-51 mg/100 ml
Lactic acid 6-16 mg/100 ml
Composition of Plasma
4/3/2024 10
Sreenu Thalla, Department of
Pharmacology
Total lipid 450-850 mg/100 ml
Cholesterol 120-220 mg/100 ml
Fatty acids 190-420 mg/100 ml
High-density lipoprotein (HDL) 30-80 mg/100 ml
Low-density lipoprotein (LDL) 62-185 mg/100 ml
Neutral Fats (triglycerides) 40-150 mg/100 ml
Phospholipids 6-12 mg/100 ml
Composition of Plasma (continued)
4/3/2024 11
Sreenu Thalla, Department of
Pharmacology
Iron 50-150 g/100 ml
Vitamins (A, B, C, D, E, K) Trace amount
Electrolytes
Sodium 135-145 mEq/L
Potassium 3.5-5.0 mEq/L
Magnesium 1.3-2.1 mEq/L
Calcium 9.2-10.4 mEq/L
Chloride 90-106 mEq/L
Bicarbonate 23.1-26.7 mEq/L
Phosphate 1.4-2.7 mEq/L
Sulfate 0.6-1.2 mEq/L
Composition of Plasma (continued)
4/3/2024 12
Sreenu Thalla, Department of
Pharmacology
Nitrogenous Wastes
Ammonia 0.02-0.09 mg/100 ml
Urea 8-25 mg/100 ml
Creatine 0.2-0.8 mg/100 ml
Creatinine 0.6-1.5 mg/100 ml
Uric acid 1.5-8.0 mg/100 ml
Bilirubin 0-1.0 mg/100 ml
Respiratory gases (O2, CO2, and N2)
Composition of Plasma (continued)
4/3/2024 13
Sreenu Thalla, Department of
Pharmacology
plasma serum
clotting proteins
(fibrin)
4/3/2024 14
Sreenu Thalla, Department of
Pharmacology
The Formed Elements
(Blood Cells)
4/3/2024 15
Sreenu Thalla, Department of
Pharmacology
Formed elements include:
Erythrocytes (red blood cells, RBCs)
Platelets (cellular fragments)
Leukocytes (white blood cells, WBCs)
Granulocytes
Agranulocytes
Neutrophils
Eosinophils
Basophils
Lymphocytes
Monocytes
4/3/2024 16
Sreenu Thalla, Department of
Pharmacology
4/3/2024 17
Sreenu Thalla, Department of
Pharmacology
4/3/2024 18
Sreenu Thalla, Department of
Pharmacology
Erythrocytes
(red blood cells)
4/3/2024 19
Sreenu Thalla, Department of
Pharmacology
Erythrocytes (Red Blood Cells, RBCs)
Appearance:
- biconcave disc shape,
which is suited for gas
exchange. The shape is
flexible so that RBCs can pass
though the smallest blood
vessels, i.e., capillaries.
4/3/2024 20
Sreenu Thalla, Department of
Pharmacology
Erythrocytes are smaller than Leukocytes.
4/3/2024 21
Sreenu Thalla, Department of
Pharmacology
Erythrocytes (Red Blood Cells, RBCs)
Structure:
-Primary cell
content is
hemoglobin,
the protein
that binds
oxygen and
carbon
dioxide.
- no nucleus
nor
mitochondria
4/3/2024 22
Sreenu Thalla, Department of
Pharmacology
Hemoglobin consists of :
globin and heme pigment
4/3/2024 23
Sreenu Thalla, Department of
Pharmacology
Globin
- Consists of two  and two  subunits
- Each subunit binds to a heme group
4/3/2024 24
Sreenu Thalla, Department of
Pharmacology
Heme Group Structure
Heme Groups
carry four molecules of oxygen
Each heme group bears an atom of iron, which binds
reversibly with one molecule of oxygen
4/3/2024 25
Sreenu Thalla, Department of
Pharmacology
Carbon monoxide competes with oxygen
for heme binding with a much higher
affinity.
Problem:
Treatment:
deoxygenate hemoglobin
hyperbaric oxygen chamber
4/3/2024 26
Sreenu Thalla, Department of
Pharmacology
Oxyhemoglobin
- bound with oxygen
- red
Deoxyhemoglobin
- free of oxygen
- dark red.
Carbaminohemoglobin
20% of carbon dioxide
in the blood binds to the
globin part of
hemoglobin, which is
called carbamino-
hemoglobin.
4/3/2024 27
Sreenu Thalla, Department of
Pharmacology
1) Primary Function
Transport oxygen from the lung to tissue cells
and carbon dioxide from tissue cells to the lung
Functions of Erythrocytes
2) Buffer blood pH
4/3/2024 28
Sreenu Thalla, Department of
Pharmacology
Production of Erythrocytes
Hematopoiesis
refers to whole blood cell
production.
Erythropoiesis
refers specifically to red
blood cell production.
All blood cells, including red and white,
are produced in red bone marrow.
On average, one ounce, or 100 billion
blood cells, are made each day.
4/3/2024 29
Sreenu Thalla, Department of
Pharmacology
Hematopoiesis
The red bone marrow is a network of reticular connective
tissue that borders on wide blood capillaries called blood
sinusoids. As hemocytoblasts mature, they migrate
through the thin walls of the sinusoids to enter the blood.
4/3/2024 30
Sreenu Thalla, Department of
Pharmacology
All of blood cells
including red and
white arise from
the same type of
stem cell, the
hematopoietic
stem cell or
hemocytoblast
4/3/2024 31
Sreenu Thalla, Department of
Pharmacology
Erythropoiesis
Erythrocytes are produced throughout
whole life to replace dead cells.
4/3/2024 32
Sreenu Thalla, Department of
Pharmacology
- regulated by renal
oxygen content.
- Erythropoietin, a
glycoprotein hormone, is
produced by renal cells
in response to a
decreased renal blood
O2 content.
- Erythropoietin
stimulates erythrocyte
production in the red
bone marrow.
Feedback Regulation of Erythropoiesis
4/3/2024 33
Sreenu Thalla, Department of
Pharmacology
A drop in renal blood oxygen level can
result from:
1) reduced numbers of red blood cells due to
hemorrhage or excess RBC destruction.
2) reduced availability of oxygen to the blood,
as might occur at high altitudes or during
pneumonia.
3) increased demands for oxygen (common in
those who are engaged in aerobic exercise).
4/3/2024 34
Sreenu Thalla, Department of
Pharmacology
Dietary Requirements for Erythropoiesis
Iron
vitamin B12
folic acid
4/3/2024 35
Sreenu Thalla, Department of
Pharmacology
The average
life span of
erythrocytes
is 120 days.
4/3/2024 36
Sreenu Thalla, Department of
Pharmacology
Anemia
is a condition in which the blood has an
abnormally low oxygen-carrying capacity.
Erythrocyte Disorders
4/3/2024 37
Sreenu Thalla, Department of
Pharmacology
Common causes of anemia include:
1) an insufficient number of red blood cells
2) decreased hemoglobin content
3) abnormal hemoglobin
Two such examples are Thalassemias and
Sickle-cell anemia, which are caused by
genetic defects.
4/3/2024 38
Sreenu Thalla, Department of
Pharmacology
Common causes of polycythemia include:
1) Bone marrow cancer
2) A response to reduced availability of
oxygen as at high altitudes
Polycythemia
is an abnormal excess of erythrocytes that
increases the viscosity of the blood, causing it
to sludge or flow sluggishly.
Erythrocyte Disorders - 2
4/3/2024 39
Sreenu Thalla, Department of
Pharmacology
Human Blood Groups
4/3/2024 40
Sreenu Thalla, Department of
Pharmacology
Human Blood Groups
- were learned from tragedies (death) caused by
mismatch during transfusion in ancient time.
- ABO blood types were identified in 1900 by Karl
Landstein (1930 Nobel laureate).
- Other blood types were identified later.
4/3/2024 41
Sreenu Thalla, Department of
Pharmacology
Blood type is determined by
Agglutinogens
• are specific
glycoproteins on red
blood cell membranes.
• All RBCs in an
individual carry the same
specific type of
agglutinogens.
4/3/2024 42
Sreenu Thalla, Department of
Pharmacology
ABO Blood Groups
Type A: RBCs carry agglutinogen A.
Type B: RBCs carry agglutinogen B.
Type O: RBCs carry no A nor B agglutinogens.
Type AB: RBCs carry both A and B agglutinogens.
4/3/2024 43
Sreenu Thalla, Department of
Pharmacology
A
- RBCs carry type A
agglutinogens.
- Plasma contain
preformed antibodies,
Agglutinin B, against
B agglutinogens.
B
B
B
B
B
Type A blood
A
A A
A
A
A A
4/3/2024 44
Sreenu Thalla, Department of
Pharmacology
Agglutinins
- are preformed antibodies in plasma
- bind to agglutinogens that are not
carried by host RBCs
- cause agglutination --- aggregation
and lysis of incompatible RBCs.
B
B
B
B
B
B
B
B
B
B
B
B
B
B B
B
B
Agglutinin B
4/3/2024 45
Sreenu Thalla, Department of
Pharmacology
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B B
B
B
B
B
B
B
B
B
B
B B
B
B
B
B
B
B
B
B
Mix Type A plasma with Type B RBCs
4/3/2024 46
Sreenu Thalla, Department of
Pharmacology
Type B recipient
4/3/2024 47
Sreenu Thalla, Department of
Pharmacology
-RBCs carry type B
agglutinogens.
- Plasma contain
agglutinin against A
agglutinogens.
Type B blood
A
A
A
A
A
A
B
B
B
B
B
B
B B
B
4/3/2024 48
Sreenu Thalla, Department of
Pharmacology
- RBCs carry neither
type A nor type B
agglutinogens.
- Plasma contain
agglutinin against
both A and B
agglutinogens.
- The person can
accept only type O
blood transfusion.
Type O blood
A
A
A
A
A
A
B
B
B
B
4/3/2024 49
Sreenu Thalla, Department of
Pharmacology
Type AB blood
Agglutinogen(s) ?
Agglutinin(s) ?
4/3/2024 50
Sreenu Thalla, Department of
Pharmacology
Type AB blood
Agglutinogen(s): A and B
No A nor B
B
A
Agglutinin(s) ?
4/3/2024 51
Sreenu Thalla, Department of
Pharmacology
Blood Type Agglutinogen
(on RBC)
Agglutinin
(in Plasma)
A A B
B B A
O A & B
AB A & B
Summary of ABO Blood Groups
4/3/2024 52
Sreenu Thalla, Department of
Pharmacology
Blood Type Match
A B O AB
A Yes No Yes? No
B No Yes Yes? No
O No No Yes No
AB Yes? Yes? Yes? Yes
R
D
4/3/2024 53
Sreenu Thalla, Department of
Pharmacology
Rh positive
- RBCs contain Rh agglutinogens.
Rh Blood Groups
Classify blood groups based on Rh agglutinogens
other than A/B agglutinogens
A
A
A
Rh
A
Rh
Rh
Rh
- The majority of human beings is Rh positive.
4/3/2024 54
Sreenu Thalla, Department of
Pharmacology
A
A A
A
B
A
A
A
A
Rh negative
- The RBCs contain no Rh agglutinogens.
- Agglutinins against Rh-positive RBCs are
produced after Rh-negative blood sees Rh-
positive RBCs.
Rh
Rh Rh
Rh
Rh
Rh
4/3/2024 55
Sreenu Thalla, Department of
Pharmacology
The problem with a Rh-negative
mother and her Rh-positive
fetus.
4/3/2024 56
Sreenu Thalla, Department of
Pharmacology
Protected by the placenta-blood
barrier, the mother is not exposed
to Rh agglutinogens until the time
of childbirth due to placental
tearing.
First Preganancy
no anti-Rh
no Rh
4/3/2024 57
Sreenu Thalla, Department of
Pharmacology
Second Pregnancy
4/3/2024 58
Sreenu Thalla, Department of
Pharmacology
Leukocytes (White Cells)
4/3/2024 59
Sreenu Thalla, Department of
Pharmacology
Leukocytes are grouped into two major categories:
Granulocytes
- contain specialized membrane-bound
cytoplasmic granules
- include neutrophils, eosinophils, and
basophils.
Agranulocytes
- lack obvious granules
- include lymphocytes and monocytes
4/3/2024 60
Sreenu Thalla, Department of
Pharmacology
4/3/2024 61
Sreenu Thalla, Department of
Pharmacology
Leukocytes (WBCs) Count
4,000-11,000 / L
4/3/2024 62
Sreenu Thalla, Department of
Pharmacology
Function of Leukocytes: defense against diseases
Leukocytes form a mobile army that helps protect
the body from damage by bacteria, viruses,
parasites, toxins and tumor cells.
4/3/2024 63
Sreenu Thalla, Department of
Pharmacology
Primary Functions of the Circulatory System
2) Protection.
cell
cell
cell
cell
cell
cell
cell
H2O
Glucose
Lipids
Amino acids
Vitamins
Minerals
O2
pH 7.35-7.45
~38° C
290 mOsm
4/3/2024 64
Sreenu Thalla, Department of
Pharmacology
Life span
- several hours to
several days for
the majority
- many years for a
few memory cells
Leukocytes circulate in the blood for
various length of time.
4/3/2024 65
Sreenu Thalla, Department of
Pharmacology
Neutrophils
- 40%-70% WBCs
- Nucleus multilobed
- Duration of development: 6-9 days
- Life Span: 6 hours to a few days
- Function: phagocytize bacteria
4/3/2024 66
Sreenu Thalla, Department of
Pharmacology
4/3/2024 67
Sreenu Thalla, Department of
Pharmacology
Eosinophils
- 1%-4% WBCs
- Nucleus bilobed
- Development:6-9 days
- Life Span: 8-12 days
- Function:
1) Kill parasitic worms
2) destroy antigen-antibody complexes
3) inactivate some inflammatory chemical of allergy
4/3/2024 68
Sreenu Thalla, Department of
Pharmacology
Basophils
- 0.5% WBCs
- Nucleus lobed
- Development: 3-7 days
- Life Span: a few hours to a few days
- Function:
1) Release histamine and other
mediators of inflammation
2) contain heparin, an anticoagulant
4/3/2024 69
Sreenu Thalla, Department of
Pharmacology
Lymphocytes
- T cells and B cells
- 20%-45% WBCs
- Nucleus spherical or indented
- Development: days to weeks
- Life Span: hours to years
- Function
Mount immune response by direct cell attack
(T cells) or via antibodies (B cells)
4/3/2024 70
Sreenu Thalla, Department of
Pharmacology
Monocytes
- 4%-8% WBCs
- Nucleus U-shaped
- Development: 2-3 days
- Life Span: months
- Function:
Phagocytosis
develop into macrophages in tissues
4/3/2024 71
Sreenu Thalla, Department of
Pharmacology
Blood Capillary
Leukocytes are deployed
in the infected areas
outside blood vessels via
3 steps.
1) Margination
2) Diapedesis
3) chemotaxis
4/3/2024 72
Sreenu Thalla, Department of
Pharmacology
Blood Capillary
slow down by cell
adhesion
molecules secreted
by endothelial cells
Leukocytes are deployed
in the infected areas
outside blood vessels via
3 steps.
1) Margination
4/3/2024 73
Sreenu Thalla, Department of
Pharmacology
Blood Capillary
2) Diapedesis:
Leukocytes slip
out of the
capillary blood
vessels.
4/3/2024 74
Sreenu Thalla, Department of
Pharmacology
Blood Capillary
3) Chemotaxis:
Gather in large
numbers at areas
of tissue damage
and infection by
following the
chemical trail of
molecules
released by
damaged cells or
other leukocytes
4/3/2024 75
Sreenu Thalla, Department of
Pharmacology
Blood Capillary
Phagocytosis
Destroy foreign
substances or
dead cells
4/3/2024 76
Sreenu Thalla, Department of
Pharmacology
Leukocyte Disorders
Normal Leukocyte Count: 4,000 – 11,000/l
Leukopenia: < 4,000/l normal leukocytes
Leukocytosis: > 11,000/l normal leukocytes
Leukopenia is one major side effect of chemotherapy.
4/3/2024 77
Sreenu Thalla, Department of
Pharmacology
- Cancerous cells grow fast, which distinguish
themselves from most of normal cells.
- Chemotherapy is designed to kill fast-growing
cells by interrupting mitotic cell division.
- Chemotherapy also kills a few normal fast-
growing cells including:
Why Leukopenia during chemotherapy?
intestinal epithelial cells
leukocytes
hair
4/3/2024 78
Sreenu Thalla, Department of
Pharmacology
Leukemia
- Leukemia refers to a group of cancerous
conditions of white blood cells.
- Descendants of a single stem cell in red
bone marrow tend to remain unspecialized
and mitotic, and suppress or impair normal
bone marrow function.
- extraordinarily high number of abnormal
(cancerous) leukocytes
4/3/2024 79
Sreenu Thalla, Department of
Pharmacology
HEMOSTASIS
4/3/2024 80
Sreenu Thalla, Department of
Pharmacology
- Hemostasis refers to the stoppage of
bleeding.
Hemostatsis = Homeostasis
Maintaining balance
Three phases occur in rapid sequence.
4/3/2024 81
Sreenu Thalla, Department of
Pharmacology
1) vascular spasms
2) platelet plug formation
3) blood clotting /
coagulation
4/3/2024 82
Sreenu Thalla, Department of
Pharmacology
Platelets
Platelets are not cells but cytoplasmic fragments of
extraordinarily large (up to 60 m in diameter) cells
called megakaryocytes.
Normal Platelet Count: 130,000 – 400,000/l
4/3/2024 83
Sreenu Thalla, Department of
Pharmacology
Function of Platelets
1) Secrete vasoconstrictors that cause vascular
spasms in broken vessels
vascular spasms
4/3/2024 84
Sreenu Thalla, Department of
Pharmacology
2) Form temporary platelet plugs to stop bleeding
4/3/2024 85
Sreenu Thalla, Department of
Pharmacology
3) Secrete chemicals that attract neutrophils and
monocytes to sites of inflammation
4/3/2024 86
Sreenu Thalla, Department of
Pharmacology
5) Dissolve blood clots that have outlast their usefulness
4) Secrete growth factors that stimulate mitosis in
fibroblasts and smooth muscle and help maintain the
linings of blood vessels
4/3/2024 87
Sreenu Thalla, Department of
Pharmacology
Coagulation (Clotting)
- Many clotting factors in
plasma are involved in
clotting.
- These factors are
inactive in the blood.
- They are activated when:
1) blood vessel is
broken, or
2) blood flow slows
down.
4/3/2024 88
Sreenu Thalla, Department of
Pharmacology
- The sequential
activation (reaction
cascade) of the clotting
factors finally leads to
the formation of fibrin
meshwork.
- Blood cells are
trapped in fibrin
meshwork to form a
hard clot.
4/3/2024 89
Sreenu Thalla, Department of
Pharmacology
Fibrinogen Fibrin Fibrin
Polymer
soluble monomer Insoluble filaments
4/3/2024 90
Sreenu Thalla, Department of
Pharmacology
4/3/2024 91
Sreenu Thalla, Department of
Pharmacology
Coagulation Disorders
Thrombosis is the abnormal clotting of blood in
an unbroken vessel.
Thrombus is a clot that attaches to the wall of
blood vessel.
Embolus is a clot that comes off the wall of blood
vessel and travel in the blood stream.
Embolism is the blockage of blood flow by an
embolus that lodges in a small blood vessel.
Infarction refers to cell death that results from
embolism. Infarction is responsible for most
strokes and heart attacks.
4/3/2024 92
Sreenu Thalla, Department of
Pharmacology
1) Thrombocytopenia
- the number of circulating platelets is deficient
(<50,000/l )
- causes spontaneous bleeding from small blood
vessels all over the body
2) Deficiency of clotting factors due to impaired liver
function
3) Hemophilias
Hereditary bleeding disorders due to deficiency of
clotting factors
Bleeding Disorders
4/3/2024 93
Sreenu Thalla, Department of
Pharmacology

More Related Content

Similar to composition and functions of Blood physiology

Chapter 2. Hematology(1).pptx
Chapter 2. Hematology(1).pptxChapter 2. Hematology(1).pptx
Chapter 2. Hematology(1).pptxSuraMAn2
 
Blood forming organs and Hematopoiesis.ppt
Blood forming organs and Hematopoiesis.pptBlood forming organs and Hematopoiesis.ppt
Blood forming organs and Hematopoiesis.pptDr.Abdulrazzak Alagbari
 
Introduction to Hematology, practical physiology
Introduction to Hematology, practical physiologyIntroduction to Hematology, practical physiology
Introduction to Hematology, practical physiologyssuser1d880f
 
A REVIEW OF HEMATOLOGY.pdf
A REVIEW OF HEMATOLOGY.pdfA REVIEW OF HEMATOLOGY.pdf
A REVIEW OF HEMATOLOGY.pdfFidelityP
 
Transport in humans part i 301_28th june
Transport in humans part i 301_28th juneTransport in humans part i 301_28th june
Transport in humans part i 301_28th junejanetsf85
 
.Cardiovascular System BLOOD 88-1_1663013474000.pptx
.Cardiovascular System  BLOOD 88-1_1663013474000.pptx.Cardiovascular System  BLOOD 88-1_1663013474000.pptx
.Cardiovascular System BLOOD 88-1_1663013474000.pptxmonthjanuary662
 
easylearningwithned.blogspot.com-The BLOOD.pdf
easylearningwithned.blogspot.com-The BLOOD.pdfeasylearningwithned.blogspot.com-The BLOOD.pdf
easylearningwithned.blogspot.com-The BLOOD.pdfHome
 
Anatomy of Circulatory system and lymphatic system
Anatomy of Circulatory system and lymphatic system Anatomy of Circulatory system and lymphatic system
Anatomy of Circulatory system and lymphatic system DR .PALLAVI PATHANIA
 
1. HEMATOLOGY (1)
1. HEMATOLOGY (1) 1. HEMATOLOGY (1)
1. HEMATOLOGY (1) Reham325065
 
blood and plasma proteins.pdfhdrhrshrhrh
blood and plasma proteins.pdfhdrhrshrhrhblood and plasma proteins.pdfhdrhrshrhrh
blood and plasma proteins.pdfhdrhrshrhrhSriRam071
 

Similar to composition and functions of Blood physiology (20)

Chapter 2. Hematology(1).pptx
Chapter 2. Hematology(1).pptxChapter 2. Hematology(1).pptx
Chapter 2. Hematology(1).pptx
 
Blood
BloodBlood
Blood
 
Blood Disorders
Blood DisordersBlood Disorders
Blood Disorders
 
Blood forming organs and Hematopoiesis.ppt
Blood forming organs and Hematopoiesis.pptBlood forming organs and Hematopoiesis.ppt
Blood forming organs and Hematopoiesis.ppt
 
Introduction to Hematology, practical physiology
Introduction to Hematology, practical physiologyIntroduction to Hematology, practical physiology
Introduction to Hematology, practical physiology
 
A REVIEW OF HEMATOLOGY.pdf
A REVIEW OF HEMATOLOGY.pdfA REVIEW OF HEMATOLOGY.pdf
A REVIEW OF HEMATOLOGY.pdf
 
Basic blood
Basic bloodBasic blood
Basic blood
 
Blood adl
Blood adlBlood adl
Blood adl
 
Transport in humans part i 301_28th june
Transport in humans part i 301_28th juneTransport in humans part i 301_28th june
Transport in humans part i 301_28th june
 
Chapter Transport Biology SPM
Chapter Transport Biology SPMChapter Transport Biology SPM
Chapter Transport Biology SPM
 
BLOOD.ppt
BLOOD.pptBLOOD.ppt
BLOOD.ppt
 
General physiology - Blood
General physiology - Blood General physiology - Blood
General physiology - Blood
 
BLOOD PHYSIOLOGY
BLOOD PHYSIOLOGY BLOOD PHYSIOLOGY
BLOOD PHYSIOLOGY
 
.Cardiovascular System BLOOD 88-1_1663013474000.pptx
.Cardiovascular System  BLOOD 88-1_1663013474000.pptx.Cardiovascular System  BLOOD 88-1_1663013474000.pptx
.Cardiovascular System BLOOD 88-1_1663013474000.pptx
 
Blood
BloodBlood
Blood
 
THE BLOOD PPT.pptx
THE BLOOD PPT.pptxTHE BLOOD PPT.pptx
THE BLOOD PPT.pptx
 
easylearningwithned.blogspot.com-The BLOOD.pdf
easylearningwithned.blogspot.com-The BLOOD.pdfeasylearningwithned.blogspot.com-The BLOOD.pdf
easylearningwithned.blogspot.com-The BLOOD.pdf
 
Anatomy of Circulatory system and lymphatic system
Anatomy of Circulatory system and lymphatic system Anatomy of Circulatory system and lymphatic system
Anatomy of Circulatory system and lymphatic system
 
1. HEMATOLOGY (1)
1. HEMATOLOGY (1) 1. HEMATOLOGY (1)
1. HEMATOLOGY (1)
 
blood and plasma proteins.pdfhdrhrshrhrh
blood and plasma proteins.pdfhdrhrshrhrhblood and plasma proteins.pdfhdrhrshrhrh
blood and plasma proteins.pdfhdrhrshrhrh
 

More from Sreenivasa Reddy Thalla

Clinical Examinations of the Abdomen with Images
Clinical Examinations of the Abdomen with ImagesClinical Examinations of the Abdomen with Images
Clinical Examinations of the Abdomen with ImagesSreenivasa Reddy Thalla
 
Head to Toe Assessment with Examinations
Head to Toe Assessment with ExaminationsHead to Toe Assessment with Examinations
Head to Toe Assessment with ExaminationsSreenivasa Reddy Thalla
 
Balanced Diet, Symptoms, Sources, Prevention, Treatment
Balanced Diet, Symptoms, Sources, Prevention, TreatmentBalanced Diet, Symptoms, Sources, Prevention, Treatment
Balanced Diet, Symptoms, Sources, Prevention, TreatmentSreenivasa Reddy Thalla
 
Pyrexia, ophthalmic symptoms and Worm Infestations
Pyrexia,  ophthalmic symptoms and Worm InfestationsPyrexia,  ophthalmic symptoms and Worm Infestations
Pyrexia, ophthalmic symptoms and Worm InfestationsSreenivasa Reddy Thalla
 
Pain and its types with pain assessment scale
Pain and its types with pain assessment scalePain and its types with pain assessment scale
Pain and its types with pain assessment scaleSreenivasa Reddy Thalla
 
Responding to symptoms of minor ailments.pptx
Responding to symptoms of minor ailments.pptxResponding to symptoms of minor ailments.pptx
Responding to symptoms of minor ailments.pptxSreenivasa Reddy Thalla
 
Clinical Pharmacotherapeutic approach of Musculoskeletal System
Clinical Pharmacotherapeutic approach of Musculoskeletal SystemClinical Pharmacotherapeutic approach of Musculoskeletal System
Clinical Pharmacotherapeutic approach of Musculoskeletal SystemSreenivasa Reddy Thalla
 
Clinical Pharmacotherapeutic approach of SPONDYLITIS
Clinical Pharmacotherapeutic approach of SPONDYLITISClinical Pharmacotherapeutic approach of SPONDYLITIS
Clinical Pharmacotherapeutic approach of SPONDYLITISSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Systemic Lupus Erythematous
Clinical Pharmacotherapy of Systemic Lupus ErythematousClinical Pharmacotherapy of Systemic Lupus Erythematous
Clinical Pharmacotherapy of Systemic Lupus ErythematousSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Rheumatoid Arthritis
Clinical Pharmacotherapy of Rheumatoid ArthritisClinical Pharmacotherapy of Rheumatoid Arthritis
Clinical Pharmacotherapy of Rheumatoid ArthritisSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Psoriasis Disease
Clinical Pharmacotherapy of Psoriasis DiseaseClinical Pharmacotherapy of Psoriasis Disease
Clinical Pharmacotherapy of Psoriasis DiseaseSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Osteoarthritis
Clinical Pharmacotherapy of OsteoarthritisClinical Pharmacotherapy of Osteoarthritis
Clinical Pharmacotherapy of OsteoarthritisSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Oral Contraceptive Pills
Clinical Pharmacotherapy of Oral Contraceptive PillsClinical Pharmacotherapy of Oral Contraceptive Pills
Clinical Pharmacotherapy of Oral Contraceptive PillsSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Impetigo.pptx
Clinical Pharmacotherapy of Impetigo.pptxClinical Pharmacotherapy of Impetigo.pptx
Clinical Pharmacotherapy of Impetigo.pptxSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Gout disease.pptx
Clinical Pharmacotherapy of Gout disease.pptxClinical Pharmacotherapy of Gout disease.pptx
Clinical Pharmacotherapy of Gout disease.pptxSreenivasa Reddy Thalla
 
Clinical Pharmacotherapy of Eczema disease.pptx
Clinical Pharmacotherapy of Eczema disease.pptxClinical Pharmacotherapy of Eczema disease.pptx
Clinical Pharmacotherapy of Eczema disease.pptxSreenivasa Reddy Thalla
 
Pharmacotherapy of Drug induced kidney disease
Pharmacotherapy of Drug induced kidney diseasePharmacotherapy of Drug induced kidney disease
Pharmacotherapy of Drug induced kidney diseaseSreenivasa Reddy Thalla
 
Pharmacotherapy of Drug induced kidney disease.pptx
Pharmacotherapy of Drug induced kidney disease.pptxPharmacotherapy of Drug induced kidney disease.pptx
Pharmacotherapy of Drug induced kidney disease.pptxSreenivasa Reddy Thalla
 
Pharmacotherapy of Chronic Renal Failure.pptx
Pharmacotherapy of Chronic Renal Failure.pptxPharmacotherapy of Chronic Renal Failure.pptx
Pharmacotherapy of Chronic Renal Failure.pptxSreenivasa Reddy Thalla
 

More from Sreenivasa Reddy Thalla (20)

Clinical Examinations of the Abdomen with Images
Clinical Examinations of the Abdomen with ImagesClinical Examinations of the Abdomen with Images
Clinical Examinations of the Abdomen with Images
 
Head to Toe Assessment with Examinations
Head to Toe Assessment with ExaminationsHead to Toe Assessment with Examinations
Head to Toe Assessment with Examinations
 
Balanced Diet, Symptoms, Sources, Prevention, Treatment
Balanced Diet, Symptoms, Sources, Prevention, TreatmentBalanced Diet, Symptoms, Sources, Prevention, Treatment
Balanced Diet, Symptoms, Sources, Prevention, Treatment
 
Pyrexia, ophthalmic symptoms and Worm Infestations
Pyrexia,  ophthalmic symptoms and Worm InfestationsPyrexia,  ophthalmic symptoms and Worm Infestations
Pyrexia, ophthalmic symptoms and Worm Infestations
 
Pain and its types with pain assessment scale
Pain and its types with pain assessment scalePain and its types with pain assessment scale
Pain and its types with pain assessment scale
 
Responding to symptoms of minor ailments.pptx
Responding to symptoms of minor ailments.pptxResponding to symptoms of minor ailments.pptx
Responding to symptoms of minor ailments.pptx
 
Clinical Pharmacotherapeutic approach of Musculoskeletal System
Clinical Pharmacotherapeutic approach of Musculoskeletal SystemClinical Pharmacotherapeutic approach of Musculoskeletal System
Clinical Pharmacotherapeutic approach of Musculoskeletal System
 
Clinical Pharmacotherapeutic approach of SPONDYLITIS
Clinical Pharmacotherapeutic approach of SPONDYLITISClinical Pharmacotherapeutic approach of SPONDYLITIS
Clinical Pharmacotherapeutic approach of SPONDYLITIS
 
Clinical Pharmacotherapy of Systemic Lupus Erythematous
Clinical Pharmacotherapy of Systemic Lupus ErythematousClinical Pharmacotherapy of Systemic Lupus Erythematous
Clinical Pharmacotherapy of Systemic Lupus Erythematous
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Clinical Pharmacotherapy of Rheumatoid Arthritis
Clinical Pharmacotherapy of Rheumatoid ArthritisClinical Pharmacotherapy of Rheumatoid Arthritis
Clinical Pharmacotherapy of Rheumatoid Arthritis
 
Clinical Pharmacotherapy of Psoriasis Disease
Clinical Pharmacotherapy of Psoriasis DiseaseClinical Pharmacotherapy of Psoriasis Disease
Clinical Pharmacotherapy of Psoriasis Disease
 
Clinical Pharmacotherapy of Osteoarthritis
Clinical Pharmacotherapy of OsteoarthritisClinical Pharmacotherapy of Osteoarthritis
Clinical Pharmacotherapy of Osteoarthritis
 
Clinical Pharmacotherapy of Oral Contraceptive Pills
Clinical Pharmacotherapy of Oral Contraceptive PillsClinical Pharmacotherapy of Oral Contraceptive Pills
Clinical Pharmacotherapy of Oral Contraceptive Pills
 
Clinical Pharmacotherapy of Impetigo.pptx
Clinical Pharmacotherapy of Impetigo.pptxClinical Pharmacotherapy of Impetigo.pptx
Clinical Pharmacotherapy of Impetigo.pptx
 
Clinical Pharmacotherapy of Gout disease.pptx
Clinical Pharmacotherapy of Gout disease.pptxClinical Pharmacotherapy of Gout disease.pptx
Clinical Pharmacotherapy of Gout disease.pptx
 
Clinical Pharmacotherapy of Eczema disease.pptx
Clinical Pharmacotherapy of Eczema disease.pptxClinical Pharmacotherapy of Eczema disease.pptx
Clinical Pharmacotherapy of Eczema disease.pptx
 
Pharmacotherapy of Drug induced kidney disease
Pharmacotherapy of Drug induced kidney diseasePharmacotherapy of Drug induced kidney disease
Pharmacotherapy of Drug induced kidney disease
 
Pharmacotherapy of Drug induced kidney disease.pptx
Pharmacotherapy of Drug induced kidney disease.pptxPharmacotherapy of Drug induced kidney disease.pptx
Pharmacotherapy of Drug induced kidney disease.pptx
 
Pharmacotherapy of Chronic Renal Failure.pptx
Pharmacotherapy of Chronic Renal Failure.pptxPharmacotherapy of Chronic Renal Failure.pptx
Pharmacotherapy of Chronic Renal Failure.pptx
 

Recently uploaded

VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...janusa9823#S0007
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyNehaa Dubey
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor rawSherrylee83
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...BabaJohn3
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?DrShinyKajal
 

Recently uploaded (20)

VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
VVIP Whitefield ℂall Girls 6350482085 Heat-flaring { Bangalore } Worthy Girl ...
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait CityIn Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
In Kuwait Abortion pills (+918133066128)@Safe abortion pills in Kuwait City
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
Case presentation on Antibody screening- how to solve 3 cell and 11 cell panel?
 

composition and functions of Blood physiology

  • 2. Primary Functions of the Circulatory System 1) Transportation - Deliver life-supporting materials, i.e., O2, glucose, amino acid, fatty acids, vitamins, minerals, etc. - Deliver regulating signals, i.e., hormones to tissue cells - Collect waste products from tissue cells and deliver to special organs (kidney, lung) for disposal - Distribute heat throughout the body 4/3/2024 2 Sreenu Thalla, Department of Pharmacology
  • 3. Primary Functions of the Circulatory System 2) Protection - Special components of the blood patrol the whole body and fight against invaded microorganisms and cancerous cells. cell cell cell cell cell cell cell H2O Glucose Lipids Amino acids Vitamins Minerals O2 pH 7.35-7.45 ~38° C 290 mOsm 4/3/2024 3 Sreenu Thalla, Department of Pharmacology
  • 4. 4/3/2024 4 Sreenu Thalla, Department of Pharmacology
  • 5. 1) Plasma 2) The Formed Elements (blood cells/cell fragments) Composition of the Blood 4/3/2024 5 Sreenu Thalla, Department of Pharmacology
  • 6. General Properties of Whole Blood - Fraction of body weight - Volume - temperature - pH 7.35 - 7.45 - Viscosity (relative to water) - Osmolarity - Mean salinity (mainly NaCl) 8% Female: 4-5 L Male: 5-6 L 38 C (100.4 F) Whole blood: 4.5-5.5 plasma: 2.0 280-300 mOsm/L 0.85% 4/3/2024 6 Sreenu Thalla, Department of Pharmacology
  • 7. Hematocrit RBCs as percent of total blood volume - Female: 37%-48% - male: 45%-52% 100% 4/3/2024 7 Sreenu Thalla, Department of Pharmacology
  • 8. Hemoglobin Female: 12-16 g/100 ml male: 13-18 g/100 ml Mean RBC count Female: 4.8 million/l male: 5.4 million/l Platelet counts 130,000-360,000/l Total WBC counts 4,000-11,000/l General Properties of Whole Blood (continued) 4/3/2024 8 Sreenu Thalla, Department of Pharmacology
  • 9. Plasma 4/3/2024 9 Sreenu Thalla, Department of Pharmacology
  • 10. Water 92% by weight Proteins Total 6-9 g/100 ml Albumin 60% of total plasma protein Globulin 36% of total plasma protein Fibrinogen 4% of total plasma protein Enzymes of diagnostic value trace Glucose (dextrose) 70-110 mg/100 ml Amino acid 33-51 mg/100 ml Lactic acid 6-16 mg/100 ml Composition of Plasma 4/3/2024 10 Sreenu Thalla, Department of Pharmacology
  • 11. Total lipid 450-850 mg/100 ml Cholesterol 120-220 mg/100 ml Fatty acids 190-420 mg/100 ml High-density lipoprotein (HDL) 30-80 mg/100 ml Low-density lipoprotein (LDL) 62-185 mg/100 ml Neutral Fats (triglycerides) 40-150 mg/100 ml Phospholipids 6-12 mg/100 ml Composition of Plasma (continued) 4/3/2024 11 Sreenu Thalla, Department of Pharmacology
  • 12. Iron 50-150 g/100 ml Vitamins (A, B, C, D, E, K) Trace amount Electrolytes Sodium 135-145 mEq/L Potassium 3.5-5.0 mEq/L Magnesium 1.3-2.1 mEq/L Calcium 9.2-10.4 mEq/L Chloride 90-106 mEq/L Bicarbonate 23.1-26.7 mEq/L Phosphate 1.4-2.7 mEq/L Sulfate 0.6-1.2 mEq/L Composition of Plasma (continued) 4/3/2024 12 Sreenu Thalla, Department of Pharmacology
  • 13. Nitrogenous Wastes Ammonia 0.02-0.09 mg/100 ml Urea 8-25 mg/100 ml Creatine 0.2-0.8 mg/100 ml Creatinine 0.6-1.5 mg/100 ml Uric acid 1.5-8.0 mg/100 ml Bilirubin 0-1.0 mg/100 ml Respiratory gases (O2, CO2, and N2) Composition of Plasma (continued) 4/3/2024 13 Sreenu Thalla, Department of Pharmacology
  • 14. plasma serum clotting proteins (fibrin) 4/3/2024 14 Sreenu Thalla, Department of Pharmacology
  • 15. The Formed Elements (Blood Cells) 4/3/2024 15 Sreenu Thalla, Department of Pharmacology
  • 16. Formed elements include: Erythrocytes (red blood cells, RBCs) Platelets (cellular fragments) Leukocytes (white blood cells, WBCs) Granulocytes Agranulocytes Neutrophils Eosinophils Basophils Lymphocytes Monocytes 4/3/2024 16 Sreenu Thalla, Department of Pharmacology
  • 17. 4/3/2024 17 Sreenu Thalla, Department of Pharmacology
  • 18. 4/3/2024 18 Sreenu Thalla, Department of Pharmacology
  • 19. Erythrocytes (red blood cells) 4/3/2024 19 Sreenu Thalla, Department of Pharmacology
  • 20. Erythrocytes (Red Blood Cells, RBCs) Appearance: - biconcave disc shape, which is suited for gas exchange. The shape is flexible so that RBCs can pass though the smallest blood vessels, i.e., capillaries. 4/3/2024 20 Sreenu Thalla, Department of Pharmacology
  • 21. Erythrocytes are smaller than Leukocytes. 4/3/2024 21 Sreenu Thalla, Department of Pharmacology
  • 22. Erythrocytes (Red Blood Cells, RBCs) Structure: -Primary cell content is hemoglobin, the protein that binds oxygen and carbon dioxide. - no nucleus nor mitochondria 4/3/2024 22 Sreenu Thalla, Department of Pharmacology
  • 23. Hemoglobin consists of : globin and heme pigment 4/3/2024 23 Sreenu Thalla, Department of Pharmacology
  • 24. Globin - Consists of two  and two  subunits - Each subunit binds to a heme group 4/3/2024 24 Sreenu Thalla, Department of Pharmacology
  • 25. Heme Group Structure Heme Groups carry four molecules of oxygen Each heme group bears an atom of iron, which binds reversibly with one molecule of oxygen 4/3/2024 25 Sreenu Thalla, Department of Pharmacology
  • 26. Carbon monoxide competes with oxygen for heme binding with a much higher affinity. Problem: Treatment: deoxygenate hemoglobin hyperbaric oxygen chamber 4/3/2024 26 Sreenu Thalla, Department of Pharmacology
  • 27. Oxyhemoglobin - bound with oxygen - red Deoxyhemoglobin - free of oxygen - dark red. Carbaminohemoglobin 20% of carbon dioxide in the blood binds to the globin part of hemoglobin, which is called carbamino- hemoglobin. 4/3/2024 27 Sreenu Thalla, Department of Pharmacology
  • 28. 1) Primary Function Transport oxygen from the lung to tissue cells and carbon dioxide from tissue cells to the lung Functions of Erythrocytes 2) Buffer blood pH 4/3/2024 28 Sreenu Thalla, Department of Pharmacology
  • 29. Production of Erythrocytes Hematopoiesis refers to whole blood cell production. Erythropoiesis refers specifically to red blood cell production. All blood cells, including red and white, are produced in red bone marrow. On average, one ounce, or 100 billion blood cells, are made each day. 4/3/2024 29 Sreenu Thalla, Department of Pharmacology
  • 30. Hematopoiesis The red bone marrow is a network of reticular connective tissue that borders on wide blood capillaries called blood sinusoids. As hemocytoblasts mature, they migrate through the thin walls of the sinusoids to enter the blood. 4/3/2024 30 Sreenu Thalla, Department of Pharmacology
  • 31. All of blood cells including red and white arise from the same type of stem cell, the hematopoietic stem cell or hemocytoblast 4/3/2024 31 Sreenu Thalla, Department of Pharmacology
  • 32. Erythropoiesis Erythrocytes are produced throughout whole life to replace dead cells. 4/3/2024 32 Sreenu Thalla, Department of Pharmacology
  • 33. - regulated by renal oxygen content. - Erythropoietin, a glycoprotein hormone, is produced by renal cells in response to a decreased renal blood O2 content. - Erythropoietin stimulates erythrocyte production in the red bone marrow. Feedback Regulation of Erythropoiesis 4/3/2024 33 Sreenu Thalla, Department of Pharmacology
  • 34. A drop in renal blood oxygen level can result from: 1) reduced numbers of red blood cells due to hemorrhage or excess RBC destruction. 2) reduced availability of oxygen to the blood, as might occur at high altitudes or during pneumonia. 3) increased demands for oxygen (common in those who are engaged in aerobic exercise). 4/3/2024 34 Sreenu Thalla, Department of Pharmacology
  • 35. Dietary Requirements for Erythropoiesis Iron vitamin B12 folic acid 4/3/2024 35 Sreenu Thalla, Department of Pharmacology
  • 36. The average life span of erythrocytes is 120 days. 4/3/2024 36 Sreenu Thalla, Department of Pharmacology
  • 37. Anemia is a condition in which the blood has an abnormally low oxygen-carrying capacity. Erythrocyte Disorders 4/3/2024 37 Sreenu Thalla, Department of Pharmacology
  • 38. Common causes of anemia include: 1) an insufficient number of red blood cells 2) decreased hemoglobin content 3) abnormal hemoglobin Two such examples are Thalassemias and Sickle-cell anemia, which are caused by genetic defects. 4/3/2024 38 Sreenu Thalla, Department of Pharmacology
  • 39. Common causes of polycythemia include: 1) Bone marrow cancer 2) A response to reduced availability of oxygen as at high altitudes Polycythemia is an abnormal excess of erythrocytes that increases the viscosity of the blood, causing it to sludge or flow sluggishly. Erythrocyte Disorders - 2 4/3/2024 39 Sreenu Thalla, Department of Pharmacology
  • 40. Human Blood Groups 4/3/2024 40 Sreenu Thalla, Department of Pharmacology
  • 41. Human Blood Groups - were learned from tragedies (death) caused by mismatch during transfusion in ancient time. - ABO blood types were identified in 1900 by Karl Landstein (1930 Nobel laureate). - Other blood types were identified later. 4/3/2024 41 Sreenu Thalla, Department of Pharmacology
  • 42. Blood type is determined by Agglutinogens • are specific glycoproteins on red blood cell membranes. • All RBCs in an individual carry the same specific type of agglutinogens. 4/3/2024 42 Sreenu Thalla, Department of Pharmacology
  • 43. ABO Blood Groups Type A: RBCs carry agglutinogen A. Type B: RBCs carry agglutinogen B. Type O: RBCs carry no A nor B agglutinogens. Type AB: RBCs carry both A and B agglutinogens. 4/3/2024 43 Sreenu Thalla, Department of Pharmacology
  • 44. A - RBCs carry type A agglutinogens. - Plasma contain preformed antibodies, Agglutinin B, against B agglutinogens. B B B B B Type A blood A A A A A A A 4/3/2024 44 Sreenu Thalla, Department of Pharmacology
  • 45. Agglutinins - are preformed antibodies in plasma - bind to agglutinogens that are not carried by host RBCs - cause agglutination --- aggregation and lysis of incompatible RBCs. B B B B B B B B B B B B B B B B B Agglutinin B 4/3/2024 45 Sreenu Thalla, Department of Pharmacology
  • 46. B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B B Mix Type A plasma with Type B RBCs 4/3/2024 46 Sreenu Thalla, Department of Pharmacology
  • 47. Type B recipient 4/3/2024 47 Sreenu Thalla, Department of Pharmacology
  • 48. -RBCs carry type B agglutinogens. - Plasma contain agglutinin against A agglutinogens. Type B blood A A A A A A B B B B B B B B B 4/3/2024 48 Sreenu Thalla, Department of Pharmacology
  • 49. - RBCs carry neither type A nor type B agglutinogens. - Plasma contain agglutinin against both A and B agglutinogens. - The person can accept only type O blood transfusion. Type O blood A A A A A A B B B B 4/3/2024 49 Sreenu Thalla, Department of Pharmacology
  • 50. Type AB blood Agglutinogen(s) ? Agglutinin(s) ? 4/3/2024 50 Sreenu Thalla, Department of Pharmacology
  • 51. Type AB blood Agglutinogen(s): A and B No A nor B B A Agglutinin(s) ? 4/3/2024 51 Sreenu Thalla, Department of Pharmacology
  • 52. Blood Type Agglutinogen (on RBC) Agglutinin (in Plasma) A A B B B A O A & B AB A & B Summary of ABO Blood Groups 4/3/2024 52 Sreenu Thalla, Department of Pharmacology
  • 53. Blood Type Match A B O AB A Yes No Yes? No B No Yes Yes? No O No No Yes No AB Yes? Yes? Yes? Yes R D 4/3/2024 53 Sreenu Thalla, Department of Pharmacology
  • 54. Rh positive - RBCs contain Rh agglutinogens. Rh Blood Groups Classify blood groups based on Rh agglutinogens other than A/B agglutinogens A A A Rh A Rh Rh Rh - The majority of human beings is Rh positive. 4/3/2024 54 Sreenu Thalla, Department of Pharmacology
  • 55. A A A A B A A A A Rh negative - The RBCs contain no Rh agglutinogens. - Agglutinins against Rh-positive RBCs are produced after Rh-negative blood sees Rh- positive RBCs. Rh Rh Rh Rh Rh Rh 4/3/2024 55 Sreenu Thalla, Department of Pharmacology
  • 56. The problem with a Rh-negative mother and her Rh-positive fetus. 4/3/2024 56 Sreenu Thalla, Department of Pharmacology
  • 57. Protected by the placenta-blood barrier, the mother is not exposed to Rh agglutinogens until the time of childbirth due to placental tearing. First Preganancy no anti-Rh no Rh 4/3/2024 57 Sreenu Thalla, Department of Pharmacology
  • 58. Second Pregnancy 4/3/2024 58 Sreenu Thalla, Department of Pharmacology
  • 59. Leukocytes (White Cells) 4/3/2024 59 Sreenu Thalla, Department of Pharmacology
  • 60. Leukocytes are grouped into two major categories: Granulocytes - contain specialized membrane-bound cytoplasmic granules - include neutrophils, eosinophils, and basophils. Agranulocytes - lack obvious granules - include lymphocytes and monocytes 4/3/2024 60 Sreenu Thalla, Department of Pharmacology
  • 61. 4/3/2024 61 Sreenu Thalla, Department of Pharmacology
  • 62. Leukocytes (WBCs) Count 4,000-11,000 / L 4/3/2024 62 Sreenu Thalla, Department of Pharmacology
  • 63. Function of Leukocytes: defense against diseases Leukocytes form a mobile army that helps protect the body from damage by bacteria, viruses, parasites, toxins and tumor cells. 4/3/2024 63 Sreenu Thalla, Department of Pharmacology
  • 64. Primary Functions of the Circulatory System 2) Protection. cell cell cell cell cell cell cell H2O Glucose Lipids Amino acids Vitamins Minerals O2 pH 7.35-7.45 ~38° C 290 mOsm 4/3/2024 64 Sreenu Thalla, Department of Pharmacology
  • 65. Life span - several hours to several days for the majority - many years for a few memory cells Leukocytes circulate in the blood for various length of time. 4/3/2024 65 Sreenu Thalla, Department of Pharmacology
  • 66. Neutrophils - 40%-70% WBCs - Nucleus multilobed - Duration of development: 6-9 days - Life Span: 6 hours to a few days - Function: phagocytize bacteria 4/3/2024 66 Sreenu Thalla, Department of Pharmacology
  • 67. 4/3/2024 67 Sreenu Thalla, Department of Pharmacology
  • 68. Eosinophils - 1%-4% WBCs - Nucleus bilobed - Development:6-9 days - Life Span: 8-12 days - Function: 1) Kill parasitic worms 2) destroy antigen-antibody complexes 3) inactivate some inflammatory chemical of allergy 4/3/2024 68 Sreenu Thalla, Department of Pharmacology
  • 69. Basophils - 0.5% WBCs - Nucleus lobed - Development: 3-7 days - Life Span: a few hours to a few days - Function: 1) Release histamine and other mediators of inflammation 2) contain heparin, an anticoagulant 4/3/2024 69 Sreenu Thalla, Department of Pharmacology
  • 70. Lymphocytes - T cells and B cells - 20%-45% WBCs - Nucleus spherical or indented - Development: days to weeks - Life Span: hours to years - Function Mount immune response by direct cell attack (T cells) or via antibodies (B cells) 4/3/2024 70 Sreenu Thalla, Department of Pharmacology
  • 71. Monocytes - 4%-8% WBCs - Nucleus U-shaped - Development: 2-3 days - Life Span: months - Function: Phagocytosis develop into macrophages in tissues 4/3/2024 71 Sreenu Thalla, Department of Pharmacology
  • 72. Blood Capillary Leukocytes are deployed in the infected areas outside blood vessels via 3 steps. 1) Margination 2) Diapedesis 3) chemotaxis 4/3/2024 72 Sreenu Thalla, Department of Pharmacology
  • 73. Blood Capillary slow down by cell adhesion molecules secreted by endothelial cells Leukocytes are deployed in the infected areas outside blood vessels via 3 steps. 1) Margination 4/3/2024 73 Sreenu Thalla, Department of Pharmacology
  • 74. Blood Capillary 2) Diapedesis: Leukocytes slip out of the capillary blood vessels. 4/3/2024 74 Sreenu Thalla, Department of Pharmacology
  • 75. Blood Capillary 3) Chemotaxis: Gather in large numbers at areas of tissue damage and infection by following the chemical trail of molecules released by damaged cells or other leukocytes 4/3/2024 75 Sreenu Thalla, Department of Pharmacology
  • 76. Blood Capillary Phagocytosis Destroy foreign substances or dead cells 4/3/2024 76 Sreenu Thalla, Department of Pharmacology
  • 77. Leukocyte Disorders Normal Leukocyte Count: 4,000 – 11,000/l Leukopenia: < 4,000/l normal leukocytes Leukocytosis: > 11,000/l normal leukocytes Leukopenia is one major side effect of chemotherapy. 4/3/2024 77 Sreenu Thalla, Department of Pharmacology
  • 78. - Cancerous cells grow fast, which distinguish themselves from most of normal cells. - Chemotherapy is designed to kill fast-growing cells by interrupting mitotic cell division. - Chemotherapy also kills a few normal fast- growing cells including: Why Leukopenia during chemotherapy? intestinal epithelial cells leukocytes hair 4/3/2024 78 Sreenu Thalla, Department of Pharmacology
  • 79. Leukemia - Leukemia refers to a group of cancerous conditions of white blood cells. - Descendants of a single stem cell in red bone marrow tend to remain unspecialized and mitotic, and suppress or impair normal bone marrow function. - extraordinarily high number of abnormal (cancerous) leukocytes 4/3/2024 79 Sreenu Thalla, Department of Pharmacology
  • 80. HEMOSTASIS 4/3/2024 80 Sreenu Thalla, Department of Pharmacology
  • 81. - Hemostasis refers to the stoppage of bleeding. Hemostatsis = Homeostasis Maintaining balance Three phases occur in rapid sequence. 4/3/2024 81 Sreenu Thalla, Department of Pharmacology
  • 82. 1) vascular spasms 2) platelet plug formation 3) blood clotting / coagulation 4/3/2024 82 Sreenu Thalla, Department of Pharmacology
  • 83. Platelets Platelets are not cells but cytoplasmic fragments of extraordinarily large (up to 60 m in diameter) cells called megakaryocytes. Normal Platelet Count: 130,000 – 400,000/l 4/3/2024 83 Sreenu Thalla, Department of Pharmacology
  • 84. Function of Platelets 1) Secrete vasoconstrictors that cause vascular spasms in broken vessels vascular spasms 4/3/2024 84 Sreenu Thalla, Department of Pharmacology
  • 85. 2) Form temporary platelet plugs to stop bleeding 4/3/2024 85 Sreenu Thalla, Department of Pharmacology
  • 86. 3) Secrete chemicals that attract neutrophils and monocytes to sites of inflammation 4/3/2024 86 Sreenu Thalla, Department of Pharmacology
  • 87. 5) Dissolve blood clots that have outlast their usefulness 4) Secrete growth factors that stimulate mitosis in fibroblasts and smooth muscle and help maintain the linings of blood vessels 4/3/2024 87 Sreenu Thalla, Department of Pharmacology
  • 88. Coagulation (Clotting) - Many clotting factors in plasma are involved in clotting. - These factors are inactive in the blood. - They are activated when: 1) blood vessel is broken, or 2) blood flow slows down. 4/3/2024 88 Sreenu Thalla, Department of Pharmacology
  • 89. - The sequential activation (reaction cascade) of the clotting factors finally leads to the formation of fibrin meshwork. - Blood cells are trapped in fibrin meshwork to form a hard clot. 4/3/2024 89 Sreenu Thalla, Department of Pharmacology
  • 90. Fibrinogen Fibrin Fibrin Polymer soluble monomer Insoluble filaments 4/3/2024 90 Sreenu Thalla, Department of Pharmacology
  • 91. 4/3/2024 91 Sreenu Thalla, Department of Pharmacology
  • 92. Coagulation Disorders Thrombosis is the abnormal clotting of blood in an unbroken vessel. Thrombus is a clot that attaches to the wall of blood vessel. Embolus is a clot that comes off the wall of blood vessel and travel in the blood stream. Embolism is the blockage of blood flow by an embolus that lodges in a small blood vessel. Infarction refers to cell death that results from embolism. Infarction is responsible for most strokes and heart attacks. 4/3/2024 92 Sreenu Thalla, Department of Pharmacology
  • 93. 1) Thrombocytopenia - the number of circulating platelets is deficient (<50,000/l ) - causes spontaneous bleeding from small blood vessels all over the body 2) Deficiency of clotting factors due to impaired liver function 3) Hemophilias Hereditary bleeding disorders due to deficiency of clotting factors Bleeding Disorders 4/3/2024 93 Sreenu Thalla, Department of Pharmacology